Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMES + Paclitaxel for Recurrent Malignant Glioma
NCT06818331Phase 2Recruiting
- Sponsor
- Third Affiliated Hospital of Zhejiang Chinese Medical University
- Start
- Feb 2025
- Primary completion
- Feb 2028
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in malignant glioma, sponsored by Third Affiliated Hospital of Zhejiang Chinese Medical University. Started Feb 2025; status: recruiting.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT06818331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06818331.